Tom Ragno, Principal and Founder of King Street Properties commended the TRG team stating, “Some of TRGB's competitors can manage the construction process, but few are as expert at the early stages of a project planning, where the success of a project is made. Working together closely with the King Street Properties' team and our tenant, Village Pharmacy, TRGB was instrumental in helping us to capture a valuable tenant for Bear Hill Business Park."
|
 |
|
| Click on image to view in detail |
|
|
• TRG BUILDERS COMPLETES 3 PRESTON COURT UPGRADES WITH ALEXANDRIA REAL ESTATE: Building on a long history with Alexandria Real Estate Equities, TRG Builders recently completed a complete renovation of 3 Preston Court in Bedford, MA converting the flex space building into a 30,000 square foot robust research core-and-shell building.
Working with Signer Harris Architects, TRG developed a design/build solution that:
- Provided new mechanical infrastructure to enable the building to accommodate virtually all research types.
- Enhanced the existing building structure to enable lab weight limits.
- Delivered additional control areas to building allowing multiple solvent-rich users.
- Created multi-tenant master plan for additional building flexibility
Alexandria Real Estate Equities, Inc.(NYSE: ARE), Landlord of Choice to the Life Science Industry®, is the largest owner and pre-eminent first-in-class REIT focused principally on science-driven cluster formation. Alexandria is the leading provider of high-quality environmentally sustainable real estate, technical infrastructure, and services to the broad and diverse life science industry. Client tenants include institutional (universities and independent not-for-profit institutions), pharmaceutical, biopharmaceutical, medical device, product, service and translational entities, as well as government agencies. Alexandria's operating platform is based on the principle of "clustering," with assets and operations located in key life science markets. Our asset base approximates 12.8 million rentable square feet consisting of 156 properties approximating 11.7 million rentable square feet (including spaces undergoing active redevelopment) and properties undergoing ground-up development approximating 1.1 million rentable square feet.
• TRG BUILDERS COMPLETES GENZYME UPGRADES: TRG Builders recently completed regulatory upgrades to two (2) facilities for Genzyme Corporation (NASDAQ: GENZ). Leveraging the TRG’s expertise in planning and constructing FDA-regulated facilities, TRG developed a three month planning cycle to design, coordinate and procure the project and implement construction in each facility in minimal time.
The first project consisted of a 15,000 square feet of new finishes, mechanical infrastructure, electrical infrastructure, and manufacturing utilities. The advance planning allowed for all equipment to be on site prior to construction start and all utility distribution to be completely coordinated. Consequently, construction was completed over seventeen (17) days, enabling Genzyme to incorporate this work into a scheduled shutdown.
The second project was slightly larger at nearly 20,000 square feet. This suite also required new finishes as well as new process utilities, new air handling units, motor control center, and exhaust fans. Similar to the first suite, all design, coordination and procurement was done in order to have all equipment available at the start of construction. The construction of this suite was also executed during a planned shutdown and was completed in twenty-one days.
Because of the aggressive time requirement of the construction schedules, TRG utilized two shifts to solidify the completion dates and help Genzyme restart manufacturing. |